Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Inspyr Therapeutics, Inc. | s105817_ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Inspyr Therapeutics, Inc. | s105817_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Inspyr Therapeutics, Inc. | s105817_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Inspyr Therapeutics, Inc. | s105817_ex31-1.htm |
| 10-K - 10-K - Inspyr Therapeutics, Inc. | s105817_10k.htm |
Exhibit 23.01
CONSENT OF INDEPENDENT REGISTERED CERTIFIED PUBLIC ACCOUNTANTS
We hereby consent to the incorporation by reference in on Registration Statement on Form S-8 (SEC File No. 333-192553) of Inspyr Therapeutics, Inc. of our report which includes an explanatory paragraph expressing substantial doubt regarding the Company’s ability to continue as a going concern dated April 17, 2017, relating to our audit of the financial statements which appear in this Annual report on Form 10-K of Inspyr Therapeutics, Inc. for the year ended December 31, 2016 and 2015.
/s/ Liggett & Webb, P.A.
April 17, 2017
New York, New York